HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer.

Abstract
alpha1,4-N-Acetylglucosaminyltransferase (alpha4GnT) is a glycosyltransferase responsible for the biosynthesis of alpha1,4-GlcNAc-capped O-glycans, and is frequently expressed in pancreatic cancer cells but not peripheral blood cells. In the present study, we tested the clinical utility of alpha4GnT mRNA expressed in the mononuclear cell fraction of peripheral blood as a biomarker of pancreatic cancer. Total RNA isolated from the peripheral blood mononuclear cells from 55 pancreatic cancer patients, 10 chronic pancreatitis patients, and 70 cancer-free volunteers was analyzed quantitatively by reverse transcription-polymerase chain reaction with primers specific for alpha4GnT, and the expression level of alpha4GnT mRNA relative to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was measured. When the ratio of alpha4GnT to GAPDH transcripts exceeded a defined cut-off value, patients were considered to have pancreatic cancer. By these standards, 76.4% of the pancreatic cancer patients were detected by this assay. A strong correlation was obtained between positivity in this assay and the expression of alpha4GnT protein detected immunohistochemically in pancreatic cancer tissues resected subsequently, suggesting that alpha4GnT mRNA detected in the peripheral blood is derived from circulating pancreatic cancer cells. Although increased levels of alpha4GnT mRNA was detected in 40.0% of chronic pancreatitis patients and 17.1% of cancer-free volunteers, the expression levels were significantly lower than those seen in pancreatic cancer patients. These results suggest that quantitative analysis of alpha4GnT mRNA expressed in the mononuclear cell fraction of peripheral blood will contribute to the detection of pancreatic cancer.
AuthorsSatoshi Ishizone, Kazuyoshi Yamauchi, Shigeyuki Kawa, Takefumi Suzuki, Fumiaki Shimizu, Oi Harada, Atsushi Sugiyama, Shinichi Miyagawa, Minoru Fukuda, Jun Nakayama
JournalCancer science (Cancer Sci) Vol. 97 Issue 2 Pg. 119-26 (Feb 2006) ISSN: 1347-9032 [Print] England
PMID16441422 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • RNA, Messenger
  • RNA, Neoplasm
  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • N-Acetylglucosaminyltransferases
  • N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (blood, metabolism)
  • Female
  • Glyceraldehyde-3-Phosphate Dehydrogenases (metabolism)
  • Humans
  • Leukocytes, Mononuclear (enzymology, pathology)
  • Male
  • Middle Aged
  • N-Acetylglucosaminyltransferases (genetics, metabolism)
  • Neoplasm Staging
  • Pancreas (enzymology, pathology)
  • Pancreatic Neoplasms (diagnosis, enzymology, genetics)
  • Pancreatitis, Chronic (diagnosis, enzymology, genetics)
  • RNA, Messenger (metabolism)
  • RNA, Neoplasm (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: